Novel Mechanisms, Molecular Targets and Therapies in Cardiovascular Disease

心血管疾病的新机制、分子靶点和疗法

• 批准号: nhmrc : 1052616
• 负责人: Prof Beng Chong
• 金额: $ 596.79万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Program Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/novel-mechanisms-molecular-cardiovascular-disease/112288
• 关键词: Novel; Mechanisms; Molecular; Targets; Therapies

Cardiovascular disease (CVD) claims 1 person every 10 min in Australia and causes 1 in 3 deaths worldwide. The molecular and cellular processes underlying atherosclerosis, vascular injury and thrombosis are highly complex and not well understood. A multifaceted approach is needed to effectively address these key challenges. This Program brings together world experts in these areas to interrogate gaps in our basic understanding of CVD, and to develop novel therapies for CVD patients by exploiting new knowledge through integrated research.

在澳大利亚，心血管疾病(CVD)每10分钟就有1人死亡，全世界每3人中就有1人死亡。动脉粥样硬化、血管损伤和血栓形成背后的分子和细胞过程是非常复杂的，而且还不是很清楚。需要采取多方面的方法来有效应对这些关键挑战。该计划将这些领域的世界专家聚集在一起，询问我们对心血管疾病基本理解中的差距，并通过综合研究利用新知识为心血管疾病患者开发新的治疗方法。